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Structured Abstract  
Objectives – We investigated whether a session of prior exercise could ameliorate 
postprandial endothelial dysfunction. 
Background – Endothelial function is impaired following fat ingestion and this may be 
related to rises in triglyceride concentrations. Exercise reduces postprandial triglyceride 
concentrations.  
Methods – Ten lean (waist <90cm) and 10 centrally obese (waist >100cm) middle-aged 
men each underwent two oral fat tolerance tests (blood taken fasting and for eight hours 
after a high-fat meal containing 80g fat and 70g carbohydrate).  On the afternoon before 
one test, subjects performed a 90-minute treadmill walk (exercise); no exercise was 
performed before the control test.  Endothelium-dependent and -independent 
microvascular function was assessed using laser Doppler imaging in the fasted state and 
at two hourly intervals during the eight-hour postprandial period.   
Results – Exercise reduced both fasting and postprandial triglyceride concentrations by 
25% in both the lean and centrally obese groups (p<0.0005).  For all subjects taken 
together, exercise improved fasting endothelium-dependent function by 25% (p<0.05) 
and, although there was a significant postprandial decrease in both endothelium-
dependent and -independent function in both the control and exercise trials (p<0.01), 
postprandial endothelium-dependent and -independent function were 15% and 20% 
higher, respectively, in the exercise trial than the control trial (both p<0.05). 
Conclusions – A session of prior exercise improves fasting and postprandial vascular 
function in middle-aged men.  This may be one mechanism by which exercise 
influences cardiovascular risk.  
 
Keywords 
 Endothelial function, exercise, lipids, postprandial 
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Condensed Abstract  
Endothelial function is impaired following fat ingestion. We investigated whether a 
session of prior exercise could ameliorate postprandial endothelial dysfunction in 20 
middle-aged men.  Subjects performed two oral fat tolerance tests: one on the day 
following a 90-minute treadmill walk, the other after no exercise. Exercise improved 
fasting endothelial function by 25% and postprandial endothelial function by 15% (both 
p<0.05). This may be one mechanism by which exercise influences cardiovascular risk. 
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Abbreviations list 
LDL – low density lipoprotein 
HDL – high density lipoprotein 
VLDL – very low density lipoprotein 
TG – triglyceride 
NEFA – non-esterified fatty acid 
IL-6 – interleukin-6 
V
.
O2 max – maximal oxygen uptake 
ELISA – enzyme-linked immunoassay 
ACh – acetylcholine 
SNP – sodium nitroprusside  
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Introduction 
Free living humans spend the majority of their lives in the postprandial state and the 
changes to metabolism seen during the hours following meal ingestion are likely to play 
an important role in the atherosclerotic disease process.  It has been postulated that 
postprandial lipoproteins and their remnants directly infiltrate the arterial wall and 
accumulate in atheromatous plaques (1).  Furthermore, high concentrations of 
postprandial lipoproteins facilitate the exchange of neutral lipids between triglyceride-
rich and cholesterol-rich lipoproteins, promoting the atherogenic lipoprotein phenotype 
of small, dense LDL and low HDL (1). 
 More recent study has focused on non-lipid disturbances occurring in the 
postprandial state.  It is now evident that systemic inflammation is increased (2,3) and 
that endothelial function is impaired (4,5) postprandially, with some studies reporting 
that the postprandial decrement in endothelial function is proportional to the 
postprandial triglyceride rise (4,5).  As endothelial dysfunction and inflammation are 
central to atherogenic progression (6), it is likely that these transient postprandial 
changes, repeated on a daily basis, have implications for long-term risk of vascular 
disease.  There is now a large body of evidence indicating that a single session of 
moderate exercise can reduce subsequent postprandial lipemia by ~20-25% (7).  Thus, 
given the reported relationship between postprandial lipemia and endothelial 
dysfunction (4,5), we hypothesized that exercise of this nature could attenuate the 
postprandial decrement in endothelial function.   
We chose to study centrally obese middle-aged men, a typical population at 
which exercise for health guidelines are targeted.  We also included a comparative 
group of lean men.  These two groups differ in insulin sensitivity (8) and exhibit marked 
differences in insulin-regulated postprandial glucose and lipid metabolism (9).  A 
secondary aim of this study was to investigate whether the magnitude of exercise-
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induced changes to postprandial metabolism would differ between these two subject 
groups with differing metabolic profiles. 
  
Methods 
Subjects 
Ten lean men (waist circumference <90 cm) and 10 age-matched centrally obese (waist 
circumference >100 cm) men participated in this study.  Their physical characteristics 
are shown in Table 1.  All were apparently healthy normoglycemic non-smokers who 
displayed no symptoms of coronary artery disease during a clinical exercise stress test.  
None was taking any drugs thought to affect lipid or carbohydrate metabolism or 
vascular function.  The study was conducted with the approval of North Glasgow 
University Hospitals NHS Trust Ethics Committee and subjects gave written informed 
consent prior to participation. 
 
Study design 
Subjects participated in two oral fat tolerance tests in a randomized, balanced design 
with an interval of 7-14 days and different pre-conditions.  In one trial, subjects walked 
on a treadmill for 90 minutes at an intensity of ~50% of maximal oxygen uptake (V
.
O2 
max) (determined from a preliminary sub-maximal incremental treadmill test (10)) on 
the day prior to the oral fat tolerance test (exercise trial).  In the other trial subjects 
performed no exercise on the day preceding the oral fat tolerance test (control trial).  
Subjects weighed and recorded their dietary intake and abstained from alcohol 
for the two days prior to the first oral fat tolerance test and replicated this prior to the 
second fat tolerance test.  In addition, subjects were instructed to perform no exercise, 
other than the treadmill walk in the exercise trial, during the three days preceding each 
oral fat tolerance test.   
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Treadmill walk  
The walk in the exercise trial was performed on the afternoon prior to the oral fat 
tolerance test and completed ~16-18 hours prior to ingestion of the test meal. Oxygen 
uptake and carbon dioxide production were measured using an online gas analysis 
system (CPX/D BreezeEx v3.0, MedGraphics Cardiorespiratory Diagnostic Systems, St 
Paul, Minnesota, USA), heart rate was measured by short range telemetry (Polar 
Electroky, Kempele, Finland) and ratings of perceived exertion (11) were obtained at 
15-minute intervals during the walk.   
 
Oral fat tolerance tests 
On the morning of the oral fat tolerance tests subjects reported to the laboratory after a 
12-h fast.  Forearm microvascular function was assessed using laser Doppler imaging 
with iontophoresis (see below for description).  A venous cannula was then inserted 
and, after an interval of 10 minutes, a baseline blood sample was withdrawn.  Subjects 
then consumed a high-fat test meal comprising whipping cream, fruit, cereal, nuts and 
chocolate which provided 80g fat, 70g carbohydrate, 12g protein and 4.3 MJ energy.  
Further blood samples were obtained 20, 40, 60, 90, 120, 240, 360 and 480 minutes 
postprandially.    Microvascular function was assessed again following the 120, 240, 
360 and 480-minute blood samples.  Subjects rested throughout this day and consumed 
only water.  This was provided ad libitum during the first fat tolerance test and the 
volume and pattern of water intake was replicated during the second test.  
 
Assessment of microvascular function  
Peripheral microvascular function was assessed using a validated technique to quantify 
vasodilator responses to iontophoresis of 1% acetylcholine (ACh, endothelium 
dependent) and 1% sodium nitroprusside (SNP, endothelium independent), which has 
been described in detail elsewhere (12,13).  Subjects lay in a semi-recumbent position in 
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a temperature-controlled room, with their non-cannulated forearm supported by an 
armrest.  Iontophoresis chambers were attached to the volar aspect of the forearm with 
ACh and SNP introduced into the anodal and cathodal chambers, respectively.  Drug 
iontophoresis was by a constant-current controller (MIC-1ev; Moor Instruments Ltd.), 
incremented from 5 µA to 20 µA (8mC total charge).  Non-invasive measurement of 
skin perfusion was by a laser Doppler imager (Moor Instruments Ltd).  Twenty 
repetitive scans were performed, including a control scan (no current).  For each scan, 
median flux values within each chamber were determined, corrected for variation in 
skin resistance (12) and the area under the corrected flux vs time curve defined the 
overall microvascular response.  The within-day and between-day coefficients of 
variation for this method are both <10% (12).     
 
Analytical procedures 
Blood samples were collected into potassium EDTA tubes and lithium heparin tubes 
and placed on ice.  Plasma was separated within 15 minutes of collection.  Plasma for 
lipoprotein analyses was stored at 4°C, the remainder was divided into aliquots and 
stored at -70°C.  In the fasted state and 8 hours postprandially, a small sample of whole 
blood was retained for the determination of white blood cell count. 
Plasma VLDL cholesterol, LDL cholesterol and HDL cholesterol concentrations 
were determined in the fasted state according to the Lipid Research Clinics Program 
Manual of Laboratory Operations (14).  TG, glucose and non-esterified fatty acid 
(NEFA) concentrations were determined by enzymatic colorimetric methods using 
commercially available kits (Roche Diagnostics GmbH, Mannheim, Germany and 
Wako Chemicals USA, Inc., VA, USA).  Insulin was determined using a commercially 
available enzyme-linked immunoassay (ELISA) with <0.01% cross-reactivity with pro-
insulin (Mercodia AB, Uppsala, Sweden).  Interleukin-6 (IL-6) concentrations were 
determined using a commercially available high-sensitivity ELISA (R&D Systems Inc., 
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Oxon, UK).   White blood cell count was measured in a Coulter counter in the routine 
hospital hematology laboratory.  Other than lipoprotein analyses and white blood cell 
count, which were performed on fresh samples, all samples for each subject were 
analyzed in the same run. Coefficients of variation were <5% for all non-ELISA assays 
and <10% all for ELISA assays.   
 
Calculations and statistics 
Energy expenditure during the 90-minute treadmill walk was calculated using indirect 
calorimetry assuming no protein oxidation (15).  
Where appropriate, the time-averaged postprandial concentration – defined as 
the trapezium rule-derived area under the plasma concentration vs time curve, divided 
by the duration of postprandial observation period (8 h) – was used as a summary 
measure of the postprandial responses.  The postprandial rise in concentration was 
defined as the time-averaged postprandial concentration minus the fasting concentration 
(i.e. the incremental area under the concentration vs time curve, divided by eight hours).   
 Statistical analyses were performed using Statistica (version 6.0, StatSoft Inc, 
Tulsa) and Minitab (version 13.1, Minitab Inc, State College).  Data sets were tested for 
normality using Anderson-Darling normality tests and, where necessary, data were 
logarithmically transformed prior to statistical analysis.  Comparisons of fasting values 
and summary postprandial responses were made using two-way ANOVA (group x trial) 
with repeated measures on the trial (exercise or control) factor.  Where it was necessary 
to determine changes over the postprandial period three-way ANOVA (group x trial x 
time) were performed with repeated measures on the trial and time factors.  Post-hoc 
Fisher LSD tests were used to identify exactly where any differences lay.  A priori 
power calculations, based on our data for intra-subject reproducibility of ACh 
vasodilator responses (within-day and between-day coefficients of variation both <10% 
(12)) and postprandial TG responses (between-day coefficient of variation 10.1%, 
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unpublished data), indicated that 10 subjects per group would enable detection of 
exercise-induced changes of ~10% in either response.  Significance was accepted at the 
P < 0.05 level and data are presented as mean ± SEM unless otherwise stated.   
 
Results 
Treadmill walk 
For the 90-minute treadmill walk, the lean men walked at a speed of 6.0 ± 0.2 km.h-1, up 
a 4.3 ± 0.6% gradient and the centrally obese men walked at 5.8 ± 0.1 km.h-1, up a 3.6 ± 
0.5% gradient.  Mean V
.
O2 and heart rate was 22.1 ± 0.9 ml.kg-1.min-1 (50.6 ± 0.9% V
.
O2max) and 119 ± 3 beat.min-1 for the lean men and 20.5 ± 0.7 ml.kg-1.min-1 (51.1 ± 
1.1% V
.
O2max) and 126 ± 3 beat.min-1 for the centrally obese men.  The lean and 
centrally obese subjects rated the intensity of the walk as 11.8 ± 0.5 (between ‘fairly 
light’ and ‘somewhat hard’) and 12.9 ± 0.5 (‘somewhat hard’), respectively, on the Borg 
scale of 6-20 (11).  There were no significant differences between the lean and centrally 
obese men in any of the above factors.  However, as a consequence of their greater body 
mass, the overall gross energy expenditure of the walk was higher in the centrally obese 
men (3.7 ± 0.1 MJ) than the lean men (2.9 ± 0.2 MJ) (p = 0.003). 
 
Plasma concentrations in the fasted state 
Plasma concentrations in the fasted state are shown in Table 2.  Concentrations of TG, 
glucose, insulin and IL-6 were all significantly higher and the concentration of HDL 
cholesterol was significantly lower in the centrally obese than the lean men (all p < 
0.05).  Exercise reduced fasting TG concentrations to the same degree in the lean and 
centrally obese men (25% reduction for both, p = 0.001).  Concentrations of NEFA 
were significantly higher in the exercise trial than the control trial.  
 
Metabolic responses to the test meal 
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Figure 1 shows the metabolic responses to the test meal with summary measures of 
these responses shown in Table 3.  As expected, the centrally obese men exhibited 
greater postprandial metabolic perturbations than the lean men with significantly higher 
postprandial plasma TG, insulin, glucose and NEFA responses.  Exercise significantly 
reduced postprandial TG concentrations (and postprandial rises in TG concentration) by 
~25% in both the lean and centrally obese groups (p < 0.0005 for both).  ANOVA main 
effects indicated that the postprandial insulin response was significantly reduced by 
exercise (p = 0.037), but post hoc analysis revealed that this was only evident in the 
centrally obese group (11% reduction, p = 0.015), with no significant reduction 
occurring in the lean subjects (3% reduction, p = 0.63).  Postprandial NEFA (p = 0.006) 
concentrations were both significantly higher the exercise trial than the control trial, but 
postprandial glucose concentrations did not differ significantly between the two trials.   
 
Microvascular responses to ACh and SNP in the fasted and postprandial states 
Microvascular responses to ACh and SNP did not differ significantly between the lean 
and centrally obese groups. Data from the two groups were therefore combined for 
further statistical analyses.  These combined responses are shown in Figure 2.  The 
fasting ACh response was 25% higher in the exercise trial than the control trial (p = 
0.02).  In both trials, the ACh responses at 2, 4, 6 and 8 hours postprandially were 
significantly lower than the responses in the fasted state (p < 0.01) but the average ACh 
response over the postprandial observation period (mean of 2, 4, 6 and 8 hour 
responses) was 15% higher in the exercise trial than the control trial (10745 ± 986 flux 
units vs 9349 ± 857 flux units, p = 0.048).   In contrast to the ACh responses, SNP 
responses did not differ significantly between the control and exercise trials in the fasted 
state (p = 0.98).  In the control trial, SNP responses at 2, 4, 6 and 8 hours postprandially 
were significantly lower than the responses in the fasted state (p < 0.01) and in the 
exercise SNP responses 4, 6 and 8 hours postprandially were significantly lower than 
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fasting values (p < 0.05).  However, the average SNP response over the postprandial 
observation period was 20% higher in the exercise trial than the control trial (11111 ± 
847 flux units vs 9230 ± 790 flux units, p = 0.036).  
 
Inflammatory responses to the test meal 
The inflammatory responses to the test meal are shown in Figure 3.  In all trials IL-6 
concentrations rose significantly following ingestion of the test meal and were 
significantly higher than concentrations in the fasted state at the late postprandial time 
points.  The time-averaged postprandial IL-6 concentration did not differ significantly 
between control and exercise trials or between the lean and centrally obese groups and 
there was no significant group x trial interaction.  White blood cell counts were 
significantly higher at 8 hours postprandially than in the fasted state in both the control 
and exercise trials for both the lean and centrally obese subject groups (all p < 0.01).  
There were no significant differences between the control and exercise trials or between 
the lean and centrally obese subjects, nor were there any significant interactions.  
 
Discussion 
The major novel finding in this study is that a single session of moderate exercise 
significantly improved small vessel vasodilator function in both the fasted and 
postprandial states in a group of middle-aged men.  Prior exercise increased the ACh 
response in the fasted state by 25%, with no change in the SNP response, indicating that 
this improvement in vascular function was endothelium dependent.  This is likely to be 
clinically important as endothelial function measures predict future cardiovascular 
events and do so independent of conventional risk factors (6).  Moreover, although it 
has been demonstrated that endothelial function can be improved following a number of 
weeks of exercise training (16), we believe that this is the first study to demonstrate an 
improvement in endothelial function sustained until the day following a single exercise 
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session.  Thus, in common with changes in TG metabolism (7) and insulin sensitivity 
(17), exercise training-induced improvements to endothelial function may, at least in 
part, be a consequence of relatively short-term changes in response to recent exercise.   
 We assessed microvascular function using the relatively novel method of laser 
Doppler imaging with iontophoresis.  This non-invasive in vivo method, which assesses 
the cutaneous microcirculation, provides a robust surrogate marker of vascular function 
in other vascular beds.  Reduced cutaneous responsiveness to iontophoresis of ACh has 
been observed in hypercholesterolaemia (18) and diabetes (19), and in these conditions 
there is a parallel reduction of the ACh response in the forearm circulation 
(predominantly a skeletal muscle vascular bed) assessed by venous occlusion 
plethysmography (20-22).  The iontophoresis method has also revealed an inverse 
relationship between blood pressure and the ACh response (23), and ACh-induced 
vasodilatation of both forearm skin and muscle is reduced in essential hypertension 
(24).  Moreover, attenuated cutaneous responses to ACh iontophoresis of heart 
transplant patients (25) are paralleled by reduced responsiveness of coronary blood 
vessels to ACh in this group (26).  Thus, many conditions affecting the cardiovascular 
system appear to result in global endothelial dysfunction, affecting cutaneous vessels as 
well as vascular beds more directly involved in the pathogenesis of vascular disease. 
 We found no significant correlations between the exercise-induced change in 
fasting TG, insulin, glucose, NEFA, IL-6 or white blood cell count, and the exercise-
induced change in the fasting ACh response (data not shown).  This is in accord with a 
recent report which found that changes to endothelial function elicited by longer-term 
exercise programs were not significantly related to the exercise-induced changes in a 
number of cardiovascular risk factors (16), suggesting that exercise may improve 
endothelial function via other mechanisms.  The improvement in the fasting ACh 
response following exercise may be due to increased blood flow augmenting shear 
stress on the endothelium, thereby stimulating nitric oxide (NO) release.  Indeed recent 
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evidence suggests that this is evident in vascular beds which are not actively exercising 
as well as in the exercising tissues (27).  Furthermore, the effects of moderate exercise 
on blood flow persist for a number of hours following exercise cessation; it has been 
reported that leg blood flow is almost 40% higher during the day following a 2-hour 
moderate intensity exercise session than following a day with no exercise (28) and that 
subcutaneous adipose tissue blood flow is elevated for a number of hours post-exercise 
(29).  This prolonged increase in blood flow during recovery from exercise may enable 
augmented endothelial function to persist for a number of hours post-exercise, in line 
with the present findings.  
 In both the control and the exercise trials, the ACh response declined 
significantly postprandially, in agreement with other reports (4,5).  However, 
postprandial ACh responses were significantly higher in the exercise trial than the 
control trial, indicating that prior exercise acted to oppose the postprandial decrement.  
Interestingly, there was a postprandial decline in the SNP response which tracked the 
decrease in the ACh response, indicating that the postprandial decrement in 
microvascular function cannot be attributed with certainty to endothelial as opposed to 
smooth muscle vascular structures.  However, as postprandial SNP responses were 
higher in the exercise than the control trial, it seems likely that prior exercise also 
ameliorated any postprandial decline in vascular smooth muscle vasoactivity.  These 
findings mirror the effects of fenofibrate on vasodilator function in 
hypertriglyceridaemic patients (30) in which fibrate treatment reduced TG 
concentrations and improved resistance vessel vasodilator responses to both ACh and 
SNP to a similar degree. Thus, it is possible that the TG-mediated impairment of 
resistance vascular function may, to some extent, be mediated by endothelium-
independent mechanisms and this may differ somewhat from the effects of TG on 
conduit vessel vascular function, where it appears that that the postprandial decrement 
in vasodilator response is mediated by endothelium dependent mechanisms (4,5).  
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Certainly, in vitro studies have demonstrated that remnants and fatty acids derived from 
the hydrolysis of TG-rich lipoproteins are cytotoxic to vascular smooth muscle cells 
(31,32).  Moreover cardiovascular risk factors such as hypercholesterolaemia (33), 
hypertension (34) and type 2 diabetes (20) have been linked to the perturbance of both 
endothelium dependent and independent vasodilation (however measured) and their 
treatments often improve both responses (22,33).    
 Since ingestion of high-fat meals blunts vasodilator function (4,5), but ingestion 
of a low-fat meal does not (4), it seems likely that the postprandial decrement in 
vascular function is a consequence of fat ingestion per se.  However, as yet, the 
mechanisms responsible have not been fully elucidated.  Some studies have reported 
that the postprandial decrement in vasodilator function correlates with the postprandial 
rise in TG (4,5), but this is not a universal finding (35) and in the present study we 
found no significant relationships between postprandial TG concentrations or rises in 
concentration and postprandial ACh responses in either the control or exercise trial (data 
not shown).  We similarly found no significant relationships between exercise-induced 
changes in postprandial TG concentrations or rises in concentration and exercise-
induced changes in postprandial ACh responses (data not shown), suggesting that 
differences in TG may not explain the changes in ACh response observed in the present 
study.  Alternatively postprandial increases in systemic inflammation may contribute to 
endothelial dysfunction (3); in the present study there was clear evidence of a 
postprandial increase in inflammation with rises in IL-6 concentrations and white blood 
cell counts.  However, we observed similar postprandial inflammatory responses in the 
control and exercise trials suggesting that either differences in these inflammatory 
markers were not a major mediator in the exercise-induced improvements to 
postprandial vasodilator responses or that the study had insufficient power to detect a 
clear effect of exercise on these inflammatory responses.  A further possibility is that 
prior exercise influenced endothelial function through effects on postprandial oxidative 
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stress or anti-oxidant mechanisms.  It has been reported that co-ingestion of anti-oxidant 
vitamins with fat abolishes the postprandial decrement in endothelial function (36) and 
moderate exercise may act though a similar mechanism as it has been demonstrated that 
moderate exercise training increases plasma antioxidant defenses (37).  Whether this 
occurs in response to a single exercise session warrants further investigation.  
Alternatively, it is possible that the higher postprandial ACh responses seen after 
exercise were a direct consequence of the higher ACh baseline response, rather than a 
specific effect of exercise on postprandial metabolism. 
 We did not observe significant differences in microvascular function between 
the lean and the centrally obese subjects in this study, however, ACh responses were, 
overall, ~10% lower in the centrally obese than the lean subjects. This difference 
between groups was substantially smaller than that observed for the postprandial TG 
response (control trial response 79% higher in the centrally obese subjects, p < 0.01, see 
Table 2) or the postprandial insulin response (106% higher, p < 0.01) and suggests that 
the effects of obesity on microvascular function may be more subtle than its effects on 
TG metabolism and insulin sensitivity. The present study, with 10 subjects in each 
group, had insufficient power to determine whether this small difference in 
microvascular function between the groups was real and further investigation in a larger 
study is warranted to address this issue. 
 The results from this study demonstrate that a session of prior moderate exercise 
effectively reduces postprandial TG concentrations in both lean and centrally obese 
middle-aged men.  The percentage reductions in TG were remarkably similar in the two 
groups – ~25% for each – but the centrally obese subjects, by virtue of their higher TG 
concentrations experienced a greater absolute TG fall.  The percentage TG reductions 
observed are comparable with those found in other reports (7).  However, these earlier 
reports have generally studied subjects with lower TG concentrations than those of the 
centrally obese subjects in the present study and thus our findings extend the evidence 
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base demonstrating the efficacy of moderate exercise in reducing postprandial lipemia 
in a range of study populations.  Importantly, despite many of the men being unused to 
walking long distances, all managed to complete the 90-minute treadmill walk without 
difficulty and none complained of undue tiredness or muscle soreness, indicating that, 
while this goes beyond the current ‘30 minutes per day’ exercise recommendation (38), 
walks of this intensity and duration are not beyond the capability of inactive centrally 
obese middle-aged men. 
 In conclusion, this study has demonstrated that a single session of moderate 
intensity exercise, which was well tolerated by the study participants, improved fasting 
and postprandial resistance vessel vasodilator function in a group of middle-aged men.  
Furthermore, prior exercise reduced postprandial lipemia to the same degree in lean and 
centrally obese men and reduced postprandial insulin concentrations in the centrally 
obese men.  These findings indicate that moderate exercise is effective in attenuating 
many of the adverse metabolic and vascular changes occurring during the hours after 
ingestion of dietary fat and thus contribute to our understanding of the mechanisms by 
which exercise can reduce cardiovascular risk.  
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Figure 1 
Postprandial plasma TG concentrations (top panels), insulin (2nd top panels), glucose 
(2nd bottom panels) and NEFA (bottom panels) concentrations in the lean (n =10, left 
panels) and centrally obese (n = 10, right panels) in the control and exercise trials.  
Summary statistics for these responses are shown in Table 3. 
 
Figure 2  
Microvascular responses to ACh (top panel) and SNP (bottom panel) in the fasted and 
postprandial states for the lean and centrally obese subjects combined in the control and 
exercise trials (n = 20).  Statistics performed on logarithmically transformed data. 
*different from fasting value in the same trial, p < 0.05 (** p < 0.01), †difference 
between control and exercise trials at the same time point, p < 0.05. 
 
Figure 3 
Postprandial plasma IL-6 (top panels) and white blood cell counts (bottom panels) in the 
lean (n =10, left panels) and centrally obese (n = 10, right panels) in the control and 
exercise trials.   different from fasting value in the same trial, p < 0.05 (** p < 0.01), 
†difference between control and exercise trials at the same time point, p < 0.05.  
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Table 1. Subject characteristics.   
 
 Lean men (n = 10) Centrally obese men (n = 10) 
Age (years) 47.9 ± 8.4 46.5 ± 10.5 
Waist (cm) 82.3 ± 5.4 107.1 ± 8.0* 
Body mass index (kg.m-2) 23.0 ± 1.9 31.7 ± 4.7* 
Sum of 4 skinfolds† 39.8 ± 8.4 88.3 ± 43.1* 
Systolic blood pressure 
(mm Hg) 
112 ± 5 118 ± 12 
Diastolic blood pressure 
(mm Hg) 
70 ± 7 74 ± 7 
Maximal oxygen uptake‡ 
(ml.kg.-1min-1)  
43.9 ± 6.2 40.6 ± 6.6 
 
Data are mean ± SD. *significantly different from lean group, p < 0.01 
†Skinfolds are biceps, triceps, subscapular and suprailiac. 
‡Estimated from a 4-stage submaximal incremental treadmill test (10).  
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Table 2. Plasma concentrations in the fasted state 
 
 Lean men (n = 10) Centrally obese men (n = 10) 
 Control Exercise Control Exercise 
 
P for 
group 
 
P for 
trial 
TG*  
(mmol.l-1)  
0.85 ± 0.08 0.64 ± 0.05 1.74 ± 0.20 1.31 ± 0.20 <0.0005 0.001 
Total cholesterol 
(mmol.l-1) 
4.96 ± 0.24 5.01 ± 0.23 5.00 ± 0.28 4.82 ± 0.23 0.82 0.38 
HDL cholesterol 
(mmol.l-1) 
1.32 ± 0.09 1.37 ± 0.09 0.97 ± 0.07 1.00 ± 0.06 0.005 0.11 
LDL cholesterol 
(mmol.l-1) 
3.24 ± 0.15 3.33 ± 0.16 3.36 ± 0.24 3.27 ± 0.22 0.92 0.99 
Glucose  
(mmol.l-1) 
5.04 ± 0.12 5.00 ± 0.10 5.60 ± 0.21 5.56 ± 0.16 0.017 0.45 
Insulin 
(µU.ml-1) 
4.03 ± 0.65 3.97 ± 0.35 7.95 ± 1.23 7.63 ± 1.54 0.017 0.63 
NEFA 
(mmol.l-1) 
0.35 ± 0.03 0.44 ± 0.03 0.44 ± 0.03 0.46 ± 0.03 0.17 0.017 
IL-6* 
(pg.ml-1) 
0.95 ± 0.14 0.78 ± 0.10 1.93 ± 0.28 1.61 ± 0.22 0.002 0.13 
 
Data are mean ± SEM.  
*Statistics performed on logarithmically transformed data 
P for group – ANOVA main effect for lean vs centrally obese 
P for trial – ANOVA main effect for control vs exercise 
No significant group by trial interactions 
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Table 3. Metabolic responses to the test meal 
 
 Lean men (n = 10) Centrally obese men (n = 10) 
 Control Exercise Control Exercise 
 
P for 
group 
 
P for 
trial 
Postprandial TG 
concentration*  
(mmol.l-1)  
1.40 ± 0.12 1.05 ± 0.07 2.51 ± 0.32 1.91 ± 0.33 0.002 <0.0005 
Postprandial TG rise 
in concentration* 
(mmol.l-1) 
0.55 ± 0.06 0.41 ± 0.04 0.77 ± 0.15 0.60 ± 0.14 0.282 <0.0005 
Postprandial insulin 
concentration*  
(µU.ml-1) 
8.61 ± 0.79 8.36 ± 0.76 17.75 ± 2.62 15.86 ± 2.96 0.003 0.037 
Postprandial glucose 
concentration   
(mmol.l-1) 
5.15 ± 0.11 5.18 ± 0.09 5.77 ± 0.14 5.73 ± 0.15 0.003 0.80 
Postprandial NEFA 
concentration   
(mmol.l-1) 
0.35 ± 0.01 0.38 ± 0.02 0.41 ± 0.02 0.45 ± 0.02 0.009 0.006 
 
Postprandial concentrations and postprandial rises in concentration calculated as the 
area under the total or incremental concentration vs time curve divided by the duration 
of the postprandial observation period (8 h). 
Data are mean ± SEM.  
*Statistics performed on logarithmically transformed data 
P for group – ANOVA main effect for lean vs centrally obese 
P for trial – ANOVA main effect for control vs exercise 
No significant group by trial interactions 
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